In a randomized, double-blind trial comparing therapy with EMCYT Capsules in 93 patients (11.5 to 15.9 mg/kg/day) or diethylstilbestrol (DES) in 93 patients (3.0 mg/day), the following adverse effects were reported:
EMCYT n=93 | DES n=93 | |
---|---|---|
CARDIOVASCULAR-RESPIRATORY | ||
Cardiac Arrest | 0 | 2 |
Cerebrovascular Accident | 2 | 0 |
Myocardial Infarction | 3 | 1 |
Thrombophlebitis | 3 | 7 |
Pulmonary Emboli | 2 | 5 |
Congestive Heart Failure | 3 | 2 |
Edema | 19 | 17 |
Dyspnea | 11 | 3 |
Leg Cramps | 8 | 11 |
Upper Respiratory Discharge | 1 | 1 |
Hoarseness | 1 | 0 |
GASTROINTESTINAL | ||
Nausea | 15 | 8 |
Diarrhea | 12 | 11 |
Minor Gastrointestinal Upset | 11 | 6 |
Anorexia | 4 | 3 |
Flatulence | 2 | 0 |
Vomiting | 1 | 1 |
Gastrointestinal Bleeding | 1 | 0 |
Burning Throat | 1 | 0 |
Thirst | 1 | 0 |
INTEGUMENTARY | ||
Rash | 1 | 4 |
Pruritus | 2 | 2 |
Dry Skin | 2 | 0 |
Pigment Changes | 0 | 3 |
Easy Bruising | 3 | 0 |
Flushing | 1 | 0 |
Night Sweats | 0 | 1 |
Fingertip—Peeling Skin | 1 | 0 |
Thinning Hair | 1 | 1 |
BREAST CHANGES | ||
Tenderness | 66 | 64 |
Enlargement | ||
Mild | 60 | 54 |
Moderate | 10 | 16 |
Marked | 0 | 5 |
MISCELLANEOUS | ||
Lethargy Alone | 4 | 3 |
Depression | 0 | 2 |
Emotional Lability | 2 | 0 |
Insomnia | 3 | 0 |
Headache | 1 | 1 |
Anxiety | 1 | 0 |
Chest Pain | 1 | 1 |
Hot Flashes | 0 | 1 |
Pain in Eyes | 0 | 1 |
Tearing of Eyes | 1 | 1 |
Tinnitus | 0 | 1 |
LABORATORY ABNORMALITIES | ||
Hematologic | ||
Leukopenia | 4 | 2 |
Thrombopenia | 1 | 2 |
Hepatic | ||
Bilirubin Alone | 1 | 5 |
Bilirubin and LDH | 0 | 1 |
Bilirubin and SGOT | 2 | 1 |
Bilirubin, LDH and SGOT | 2 | 0 |
LDH and/or SGOT | 31 | 28 |
Miscellaneous | ||
Hypercalcemia—Transient | 0 | 1 |
In a randomized, double-blind trial comparing therapy with EMCYT Capsules in 93 patients (11.5 to 15.9 mg/kg/day) or diethylstilbestrol (DES) in 93 patients (3.0 mg/day), the following adverse effects were reported:
EMCYT n=93 | DES n=93 | |
---|---|---|
CARDIOVASCULAR-RESPIRATORY | ||
Cardiac Arrest | 0 | 2 |
Cerebrovascular Accident | 2 | 0 |
Myocardial Infarction | 3 | 1 |
Thrombophlebitis | 3 | 7 |
Pulmonary Emboli | 2 | 5 |
Congestive Heart Failure | 3 | 2 |
Edema | 19 | 17 |
Dyspnea | 11 | 3 |
Leg Cramps | 8 | 11 |
Upper Respiratory Discharge | 1 | 1 |
Hoarseness | 1 | 0 |
GASTROINTESTINAL | ||
Nausea | 15 | 8 |
Diarrhea | 12 | 11 |
Minor Gastrointestinal Upset | 11 | 6 |
Anorexia | 4 | 3 |
Flatulence | 2 | 0 |
Vomiting | 1 | 1 |
Gastrointestinal Bleeding | 1 | 0 |
Burning Throat | 1 | 0 |
Thirst | 1 | 0 |
INTEGUMENTARY | ||
Rash | 1 | 4 |
Pruritus | 2 | 2 |
Dry Skin | 2 | 0 |
Pigment Changes | 0 | 3 |
Easy Bruising | 3 | 0 |
Flushing | 1 | 0 |
Night Sweats | 0 | 1 |
Fingertip—Peeling Skin | 1 | 0 |
Thinning Hair | 1 | 1 |
BREAST CHANGES | ||
Tenderness | 66 | 64 |
Enlargement | ||
Mild | 60 | 54 |
Moderate | 10 | 16 |
Marked | 0 | 5 |
MISCELLANEOUS | ||
Lethargy Alone | 4 | 3 |
Depression | 0 | 2 |
Emotional Lability | 2 | 0 |
Insomnia | 3 | 0 |
Headache | 1 | 1 |
Anxiety | 1 | 0 |
Chest Pain | 1 | 1 |
Hot Flashes | 0 | 1 |
Pain in Eyes | 0 | 1 |
Tearing of Eyes | 1 | 1 |
Tinnitus | 0 | 1 |
LABORATORY ABNORMALITIES | ||
Hematologic | ||
Leukopenia | 4 | 2 |
Thrombopenia | 1 | 2 |
Hepatic | ||
Bilirubin Alone | 1 | 5 |
Bilirubin and LDH | 0 | 1 |
Bilirubin and SGOT | 2 | 1 |
Bilirubin, LDH and SGOT | 2 | 0 |
LDH and/or SGOT | 31 | 28 |
Miscellaneous | ||
Hypercalcemia—Transient | 0 | 1 |
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.